home All News open_in_new Full Article

Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ®™

New patents provide additional composition of matter and methods of use claims, strengthening the protection for liquid oral taste-masked reformulation, LIKMEZ New subject matter listed in the U.S. Food and Drug Administration’s (“FDA”) Orange Book HALIFAX, Nova Scotia, April 28, 2025 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a […]


today 4 h. ago attach_file Other

attach_file Other
attach_file Other
attach_file Economics
attach_file Events
attach_file Society
attach_file Society
attach_file Economics
attach_file Other
attach_file Economics
attach_file Economics
attach_file Other
attach_file Other
attach_file Culture
attach_file Events
attach_file Economics
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Economics


ID: 3671389322
Add Watch Country

arrow_drop_down